Zobrazeno 1 - 10
of 1 347
pro vyhledávání: '"Gusenleitner, A."'
Autor:
Chia-Chi Lin, Elena Garralda, Patrick Schöffski, David S. Hong, Lillian L. Siu, Miguel Martin, Michela Maur, Rina Hui, Ross A Soo, Joanne Chiu, Tian Zhang, Brigette Ma, Chrisann Kyi, Daniel SW Tan, Philippe A. Cassier, John Sarantopoulos, Andrew Weickhardt, Richard D. Carvajal, Jennifer Spratlin, Taito Esaki, Fréderic Rolland, Wallace Akerley, Barbara Deschler-Baier, Lawrence Rispoli, Tanay S. Samant, Niladri Roy Chowdhury, Daniel Gusenleitner, Eunice L. Kwak, Vasileios Askoxylakis, Filippo De Braud
Publikováno v:
OncoImmunology, Vol 13, Iss 1 (2024)
Ieramilimab, a humanized anti-LAG-3 monoclonal antibody, was well tolerated in combination with the anti-PD-1 antibody spartalizumab in a phase 1 study. This phase 2 study aimed to further investigate the efficacy and safety of combination treatment
Externí odkaz:
https://doaj.org/article/fba32163599d40e7abcb0008f2589a1a
Autor:
Salem, Daniel P., Bortolin, Laura T., Gusenleitner, Dan, Grosha, Jonian, Zabroski, Ibukunoluwapo O., Biette, Kelly M., Banerjee, Sanchari, Sedlak, Christopher R., Byrne, Delaney M., Hamzeh, Bilal F., King, MacKenzie S., Cuoco, Lauren T., Santos-Heiman, Timothy, Barcaskey, Gabrielle N., Yang, Katherine S., Duff, Peter A., Winn-Deen, Emily S., Guettouche, Toumy, Mattoon, Dawn R., Huang, Eric K., Schekman, Randy W., Couvillon, Anthony D., Sedlak, Joseph C.
Publikováno v:
In The Journal of Molecular Diagnostics December 2024 26(12):1109-1128
Autor:
Winn-Deen, Emily S., Bortolin, Laura T., Gusenleitner, Daniel, Biette, Kelly M., Copeland, Karen, Gentry-Maharaj, Aleksandra, Apostolidou, Sophia, Couvillon, Anthony D., Salem, Daniel P., Banerjee, Sanchari, Grosha, Jonian, Zabroski, Ibukunoluwapo O., Sedlak, Christopher R., Byrne, Delaney M., Hamzeh, Bilal F., King, MacKenzie S., Cuoco, Lauren T., Duff, Peter A., Manning, Brendan J., Hawkins, Troy B., Mattoon, Dawn, Guettouche, Toumy, Skates, Steven J., Jamieson, Amy, McAlpine, Jessica N., Huntsman, David, Menon, Usha
Publikováno v:
In The Journal of Molecular Diagnostics December 2024 26(12):1129-1148
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Griffin, Gabriel K. *, Weirather, Jason L. *, Roemer, Margaretha G.M. *, Lipschitz, Mikel, Kelley, Alyssa, Chen, Pei-Hsuan, Gusenleitner, Daniel, Jeter, Erin, Pak, Christine, Gjini, Evisa, Chapuy, Bjoern, Rosenthal, Michael H., Xu, Jie, Chen, Benjamin J., Sohani, Aliyah R., Lovitch, Scott B., Abramson, Jeremy S., Ishizuka, Jeffrey J., Kim, Austin I., Jacobson, Caron A., LaCasce, Ann S., Fletcher, Christopher D., Neuberg, Donna, Freeman, Gordon J., Hodi, F. Stephen, Wright, Kyle, Ligon, Azra H., Jacobsen, Eric D., Armand, Philippe, Shipp, Margaret A., Rodig, Scott J. *
Publikováno v:
In Blood 11 March 2021 137(10):1353-1364
Autor:
Dirk Schadendorf, Caroline Robert, Antoni Ribas, Reinhard Dummer, Paolo A Ascierto, Georgina V Long, Daniel Gusenleitner, Eduard Gasal, Hussein A Tawbi, Alexander Savchenko, Jan C Brase, Paul D Nathan, James Garrett, Keith T Flaherty, Güllü Görgün
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 6 (2022)
Externí odkaz:
https://doaj.org/article/8882610ebdfd455191e99301f24137f9
Autor:
Dummer, Reinhard *, Brase, Jan C, Garrett, James, Campbell, Catarina D, Gasal, Eduard, Squires, Matthew, Gusenleitner, Daniel, Santinami, Mario, Atkinson, Victoria, Mandalà, Mario, Chiarion-Sileni, Vanna, Flaherty, Keith, Larkin, James, Robert, Caroline, Kefford, Richard, Kirkwood, John M, Hauschild, Axel, Schadendorf, Dirk, Long, Georgina V
Publikováno v:
In The Lancet Oncology March 2020 21(3):358-372
Autor:
Tian Zhang, Filippo de Braud, Taito Esaki, Wallace Akerley, Chrisann Kyi, Richard D Carvajal, Daniel Gusenleitner, Patrick Schöffski, Miguel Martin, David S Hong, Amy Prawira, Jürgen Krauß, Nidhi Patel, Rina Hui, Andrew Weickhardt, Niladri Roy Chowdhury, Daniel S W Tan, María Ochoa-de-Olza, John Sarantopoulos, Ross A Soo, Michela Maur, Barbara Deschler-Baier, Allen Lau, Tanay S Samant, Tyler Longmire, Catherine A Sabatos-Peyton, Radha Ramesh, Tiancen Hu, Ana Carion, Padmaja Yerramilli-Rao, Vasileios Askoxylakis, Eunice L Kwak
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 2 (2022)
Background Lymphocyte-activation gene 3 (LAG-3) is an inhibitory immunoreceptor that negatively regulates T-cell activation. This paper presents preclinical characterization of the LAG-3 inhibitor, ieramilimab (LAG525), and phase I data for the treat
Externí odkaz:
https://doaj.org/article/c14ae2c468844f0d8af45992b1b6b8f2
Autor:
Shukla, Sachet A., Bachireddy, Pavan, Schilling, Bastian, Galonska, Christina, Zhan, Qian, Bango, Clyde, Langer, Rupert, Lee, Patrick C., Gusenleitner, Daniel, Keskin, Derin B., Babadi, Mehrtash, Mohammad, Arman, Gnirke, Andreas, Clement, Kendell, Cartun, Zachary J., Van Allen, Eliezer M., Miao, Diana, Huang, Ying, Snyder, Alexandra, Merghoub, Taha, Wolchok, Jedd D., Garraway, Levi A., Meissner, Alexander, Weber, Jeffrey S., Hacohen, Nir, Neuberg, Donna, Potts, Patrick R., Murphy, George F., Lian, Christine G., Schadendorf, Dirk, Hodi, F. Stephen, Wu, Catherine J.
Publikováno v:
In Cell 19 April 2018 173(3):624-633
Autor:
Priyanka B. Subrahmanyam, Zhiwan Dong, Daniel Gusenleitner, Anita Giobbie-Hurder, Mariano Severgnini, Jun Zhou, Michael Manos, Lauren M. Eastman, Holden T. Maecker, F. Stephen Hodi
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 6, Iss 1, Pp 1-14 (2018)
Abstract Background While immune checkpoint blockade has greatly improved clinical outcomes in diseases such as melanoma, there remains a need for predictive biomarkers to determine who will likely benefit most from which therapy. To date, most bioma
Externí odkaz:
https://doaj.org/article/0b4e970d2cb54a8e9cd3f79ea9e5e8c9